Skip to content
10-Q

Quarterly Report

Quince Therapeutics, Inc. QNCX

0001193125-25-277529

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 6, 2025 55.68M sh
Shares Diluted Q3 2025 · Sep 30, 2025 53.95M sh
Shares Diluted Q3 2025 · Sep 30, 2025 48.23M sh
Shares Diluted Q3 2025 · Sep 30, 2024 43.16M sh
Shares Diluted Q3 2025 · Sep 30, 2024 43.09M sh
Capex Q3 2025 · Sep 30, 2025 $348K
Capex Q3 2025 · Sep 30, 2024 $124K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$30.94M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$24.35M
Long Term Debt Q3 2025 · Sep 30, 2025 $0
Long Term Debt Q3 2025 · Dec 31, 2024 $14.32M
Short Term Debt Q3 2025 · Sep 30, 2025 $17.52M
Short Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $6.45M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $6.21M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.06M
Stockholders Equity Q3 2025 · Jun 30, 2025 $11.74M
Stockholders Equity Q3 2025 · Dec 31, 2024 $30.15M
Stockholders Equity Q3 2025 · Sep 30, 2024 $44.93M
Stockholders Equity Q3 2025 · Jun 30, 2024 $46.97M
Stockholders Equity Q3 2025 · Dec 31, 2023 $85.08M
Current Liabilities Q3 2025 · Sep 30, 2025 $26.04M
Current Liabilities Q3 2025 · Dec 31, 2024 $7.28M
Total Liabilities Q3 2025 · Sep 30, 2025 $108.84M
Total Liabilities Q3 2025 · Dec 31, 2024 $84.33M
Current Assets Q3 2025 · Sep 30, 2025 $29.2M
Current Assets Q3 2025 · Dec 31, 2024 $44.04M
Total Assets Q3 2025 · Sep 30, 2025 $109.9M
Total Assets Q3 2025 · Dec 31, 2024 $114.48M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.25
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.92
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.13
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.03
Eps Basic Q3 2025 · Sep 30, 2025 −$0.25
Eps Basic Q3 2025 · Sep 30, 2025 −$0.92
Eps Basic Q3 2025 · Sep 30, 2024 −$0.13
Eps Basic Q3 2025 · Sep 30, 2024 −$1.03
Sga Expense Q3 2025 · Sep 30, 2025 $3.28M
Sga Expense Q3 2025 · Sep 30, 2025 $11.41M
Sga Expense Q3 2025 · Sep 30, 2024 $3.63M
Sga Expense Q3 2025 · Sep 30, 2024 $13.3M
Rd Expense Q3 2025 · Sep 30, 2025 $8.08M
Rd Expense Q3 2025 · Sep 30, 2025 $22.78M
Rd Expense Q3 2025 · Sep 30, 2024 $4.92M
Rd Expense Q3 2025 · Sep 30, 2024 $12.77M
Net Income Q3 2025 · Sep 30, 2025 −$13.44M
Net Income Q3 2025 · Sep 30, 2025 −$44.52M
Net Income Q3 2025 · Sep 30, 2024 −$5.49M
Net Income Q3 2025 · Sep 30, 2024 −$44.37M
Operating Income Q3 2025 · Sep 30, 2025 −$13.43M
Operating Income Q3 2025 · Sep 30, 2025 −$38.72M
Operating Income Q3 2025 · Sep 30, 2024 −$5.86M
Operating Income Q3 2025 · Sep 30, 2024 −$45.27M